Compare PAYS & SIBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PAYS | SIBN |
|---|---|---|
| Founded | 2001 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 780.3M | 778.8M |
| IPO Year | 2020 | 2018 |
| Metric | PAYS | SIBN |
|---|---|---|
| Price | $14.87 | $21.51 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 9 |
| Target Price | $14.10 | ★ $25.44 |
| AVG Volume (30 Days) | ★ 813.3K | 525.5K |
| Earning Date | 11-09-2026 | 11-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 85.71 | 41.33 |
| EPS | ★ 0.20 | N/A |
| Revenue | $24,120,434.00 | ★ $67,301,000.00 |
| Revenue This Year | $39.78 | $15.53 |
| Revenue Next Year | $16.56 | $15.64 |
| P/E Ratio | $76.00 | ★ N/A |
| Revenue Growth | N/A | ★ 21.53 |
| 52 Week Low | $3.08 | $11.48 |
| 52 Week High | $16.15 | $21.89 |
| Indicator | PAYS | SIBN |
|---|---|---|
| Relative Strength Index (RSI) | 54.37 | 69.36 |
| Support Level | $14.30 | $16.34 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 0.78 | 0.70 |
| MACD | -0.07 | 0.22 |
| Stochastic Oscillator | 34.89 | 94.26 |
PaySign Inc is a provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing designed for businesses, consumers, and government institutions. The company creates customized payment solutions for clients across industries, including pharmaceutical, healthcare, hospitality, and retail. The The company generates revenues from pharma card programs through card program management fees, transaction claim processing fees, interchange fees, customer service fees, other billable service fees and settlement income and other revenues are generated through cardholder fees, interchange fees, program management fees, load fees and breakage.
SI-BONE Inc is a medical device company that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ, and iFuse Bedrock Granite, which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.